Primary |
Depression |
56.4% |
Anxiety |
8.1% |
Major Depression |
6.8% |
Hypertension |
4.2% |
Product Used For Unknown Indication |
3.9% |
Panic Attack |
2.4% |
Panic Disorder |
2.1% |
Psychotic Disorder |
2.0% |
Generalised Anxiety Disorder |
1.8% |
Bipolar Disorder |
1.6% |
Pain |
1.6% |
Insomnia |
1.2% |
Obsessive-compulsive Disorder |
1.2% |
Postpartum Depression |
1.2% |
Atrial Fibrillation |
1.0% |
Suicide Attempt |
1.0% |
Sleep Disorder |
0.9% |
Social Phobia |
0.9% |
Parkinson's Disease |
0.8% |
Depressive Symptom |
0.8% |
|
Product Substitution Issue |
9.3% |
Suicide Attempt |
7.7% |
Suicidal Ideation |
7.6% |
Tremor |
7.2% |
Vomiting |
6.8% |
Hyponatraemia |
6.0% |
Somnolence |
5.5% |
Overdose |
5.3% |
Pregnancy |
4.9% |
Weight Increased |
4.8% |
Withdrawal Syndrome |
4.0% |
Weight Decreased |
3.9% |
Off Label Use |
3.8% |
Serotonin Syndrome |
3.7% |
Completed Suicide |
3.5% |
Loss Of Consciousness |
3.5% |
Drug Interaction |
3.3% |
Urinary Retention |
3.3% |
Convulsion |
3.2% |
Epilepsy |
2.8% |
|
Secondary |
Product Used For Unknown Indication |
26.1% |
Depression |
25.0% |
Drug Use For Unknown Indication |
18.3% |
Anxiety |
5.1% |
Major Depression |
3.2% |
Panic Attack |
3.0% |
Suicide Attempt |
2.6% |
Hypertension |
2.2% |
Psychotic Disorder |
1.9% |
Schizoaffective Disorder |
1.9% |
Postpartum Depression |
1.8% |
Pain |
1.2% |
Panic Disorder |
1.2% |
Bipolar Disorder |
1.1% |
Pyrexia |
1.1% |
Insomnia |
1.0% |
Schizophrenia |
0.9% |
Sleep Disorder |
0.9% |
Social Phobia |
0.8% |
Generalised Anxiety Disorder |
0.7% |
|
Completed Suicide |
21.7% |
Toxicity To Various Agents |
9.0% |
Suicide Attempt |
6.5% |
Death |
6.1% |
Serotonin Syndrome |
6.1% |
Respiratory Arrest |
5.9% |
Overdose |
4.3% |
Somnolence |
4.3% |
Tremor |
4.2% |
Poisoning |
4.1% |
Vomiting |
4.1% |
Drug Toxicity |
3.5% |
Weight Increased |
3.0% |
Suicidal Ideation |
2.8% |
Hyponatraemia |
2.6% |
Tachycardia |
2.6% |
Pregnancy |
2.5% |
Weight Decreased |
2.3% |
Syncope |
2.2% |
Withdrawal Syndrome |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
31.1% |
Depression |
15.4% |
Drug Use For Unknown Indication |
8.4% |
Hypertension |
5.9% |
Anxiety |
5.1% |
Pain |
4.8% |
Rheumatoid Arthritis |
3.3% |
Hepatitis C |
3.0% |
Multiple Sclerosis |
2.8% |
Schizophrenia |
2.8% |
Bipolar Disorder |
2.3% |
Diabetes Mellitus |
2.2% |
Prophylaxis |
2.1% |
Insomnia |
2.0% |
Sleep Disorder |
1.7% |
Crohn's Disease |
1.5% |
Breast Cancer |
1.4% |
Asthma |
1.4% |
Hiv Infection |
1.4% |
Atrial Fibrillation |
1.3% |
|
Vomiting |
8.3% |
Pyrexia |
6.8% |
Weight Decreased |
6.8% |
White Blood Cell Count Increased |
6.2% |
Weight Increased |
5.7% |
Nausea |
5.5% |
Somnolence |
5.4% |
Urinary Tract Infection |
5.4% |
Death |
5.0% |
Psychotic Disorder |
4.9% |
Tachycardia |
4.5% |
White Blood Cell Count Decreased |
4.5% |
Pulmonary Embolism |
4.2% |
Renal Failure Acute |
4.0% |
Depression |
3.8% |
Diarrhoea |
3.8% |
Overdose |
3.8% |
Pain In Extremity |
3.8% |
Sepsis |
3.8% |
Withdrawal Syndrome |
3.8% |
|
Interacting |
Product Used For Unknown Indication |
26.2% |
Depression |
17.3% |
Parkinson's Disease |
8.6% |
Hypertension |
7.0% |
Anxiety |
6.0% |
Intentional Overdose |
4.0% |
Prophylaxis |
3.7% |
Pneumonia Bacterial |
3.3% |
Psoriatic Arthropathy |
3.3% |
Relapsing-remitting Multiple Sclerosis |
3.3% |
Hiv Infection |
2.7% |
Pain |
2.0% |
Agitation |
1.7% |
Arrhythmia |
1.7% |
Back Disorder |
1.7% |
Bipolar Disorder |
1.7% |
Drug Use For Unknown Indication |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Back Pain |
1.3% |
Bipolar I Disorder |
1.3% |
|
Drug Interaction |
31.2% |
Serotonin Syndrome |
16.9% |
Epistaxis |
5.2% |
Tremor |
5.2% |
Somnolence |
3.9% |
Abnormal Sensation In Eye |
2.6% |
Acute Psychosis |
2.6% |
Balance Disorder |
2.6% |
Dyspnoea |
2.6% |
Gastrointestinal Inflammation |
2.6% |
Hyperhidrosis |
2.6% |
Hyponatraemia |
2.6% |
Long Qt Syndrome |
2.6% |
Lymphocyte Count Decreased |
2.6% |
Mydriasis |
2.6% |
Rhabdomyolysis |
2.6% |
Suicidal Ideation |
2.6% |
Vomiting |
2.6% |
Weight Decreased |
2.6% |
Abnormal Weight Gain |
1.3% |
|